Certificate Number

GMPC or Non Compliance

Site Name

Site Address

City

Postcode

Country

Total Records 81 to 90 of 308
Download
GMP Search Results
Certificate Number GMPC or Non-compliance Site Details Country Inspection Date
UK GMP 20788 Insp GMP 20788/13917-0005[H] GMPC

PATHEON PHARMACEUTICALS INCORPORATED, 2110 EAST GALBRAITH ROAD, CINCINNATI, 45237, UNITED STATES

UNITED STATES
UK GMP 19196 Insp GMP 23092/1470275-0004[H] GMPC

ACTAVIS LABORATORIES NY, INC. (SUBSIDIARY OF TEVA PHARMACEUTICALS USA, INC.), 26 BETHPAGE ROAD, COPIAGUE, 11726-0030, UNITED STATES

UNITED STATES
UK GMP 17043 Insp GMP 17043/5906815-0003[H] GMPC

UNITED THERAPEUTICS CORP., 1040 SPRING STREET, SILVER SPRING, 20910, UNITED STATES

UNITED STATES
UK GMP 23083 Insp GMP 23083/1880916-0002[H] GMPC

QILU PHARMACEUTICAL CO. LIMITED, NO. 317, XINLUO ROAD, HIGH-TECH ZONE, JINAN, CN-250101, CHINA

CHINA
UK GMP 35774 Insp GMP 35774/9055077-0003 [V] GMPC

ALCAMI CAROLINAS CORPORATION, 1726 NORTH 23RD STREET, WILMINGTON, 28405, UNITED STATES

UNITED STATES
UK GMP 35774 Insp GMP 35774/10895317-0003 [V] GMPC

ALCAMI CAROLINAS CORPORATION, 1519 NORTH 23RD STREET, WILMINGTON, 28405, UNITED STATES

UNITED STATES
UK GMP 35774 Insp GMP 35774/13104735-0002 [H] GMPC

ALCAMI CAROLINAS CORPORATION, QUALITY CONTROL LABORATORY, 2320 SCIENTIFIC PARK DRIVE, WILMINGTON, 28405, UNITED STATES

UNITED STATES
UK GMP 35774 Insp GMP 35774/9055077-0003 [H] GMPC

ALCAMI CAROLINAS CORPORATION, 1726 NORTH 23RD STREET, WILMINGTON, 28405, UNITED STATES

UNITED STATES
UK GMP 35774 Insp GMP 35774/10895317-0003 [H] GMPC

ALCAMI CAROLINAS CORPORATION, 1519 NORTH 23RD STREET, WILMINGTON, 28405, UNITED STATES

UNITED STATES
UK GMP 35774 Insp GMP 35774/13104735-0002 [V] GMPC

ALCAMI CAROLINAS CORPORATION, QUALITY CONTROL LABORATORY, 2320 SCIENTIFIC PARK DRIVE, WILMINGTON, 28405, UNITED STATES

UNITED STATES

Due to the restrictions caused by COVID-19, the period of validity GMP and GDP certificates issued by MHRA is automatically extended until the end of 2024, except where clarifying remarks in the document state otherwise. Manufacturers, importers and distributors must continue to comply with GMP/GDP and all other legal obligations. On-site inspections are now being conducted and scheduling of these inspections may be independent of the extended validity period stated above. MHRA reserve the right to perform risk based supervision of sites by either on-site inspections or distant assessments and, based on the outcome, may continue to issue, withdraw or restrict GMP and GDP certificates, as appropriate.

Download XLSX